Application of models of defibrillation to human defibrillation data: implications for optimizing implantable defibrillator capacitance.

BACKGROUND Theoretical models predict that optimal capacitance for implantable cardioverter-defibrillators (ICDs) is proportional to the time-dependent parameter of the strength-duration relationship. The hyperbolic model gives this relationship for average current in terms of the chronaxie (t(c)). The exponential model gives the relationship for leading-edge current in terms of the membrane time constant (tau(m)). We hypothesized that these models predict results of clinical studies of ICD capacitance if human time constants are used. METHODS AND RESULTS We studied 12 patients with epicardial ICDs and 15 patients with transvenous ICDs. Defibrillation threshold (DFT) was determined for 120-microF monophasic capacitive-discharge pulses at pulse widths of 1.5, 3.0, 7.5, and 15 ms. To compare the predictions of the average-current versus leading-edge-current methods, we derived a new exponential average-current model. We then calculated individual patient time parameters for each model. Model predictions were validated by retrospective comparison with clinical crossover studies of small-capacitor and standard-capacitor waveforms. All three models provided a good fit to the data (r2=.88 to .97, P<.001). Time constants were lower for transvenous pathways (53+/-7 omega) than epicardial pathways (36+/-6 omega) (t(c), P<.001; average-current tau(m), P=.002; leading-edge-current tau(m), P<.06). For epicardial pathways, optimal capacitance was greater for either average-current model than for the leading-edge-current model (P<.001). For transvenous pathways, optimal capacitance differed for all three models (P<.001). All models provided a good correlation with the effect of capacitance on DFT in previous clinical studies: r2=.75 to .84, P<.003. For 90-microF, 120-microF, and 150-microF capacitors, predicted stored-energy DFTs were 3% to 8%, 8% to 16%, and 14% to 26% above that for the optimal capacitance. CONCLUSIONS Model predictions based on measured human cardiac-muscle time parameter have a good correlation with clinical studies of ICD capacitance. Most of the predicted reduction in DFT can be achieved with approximately 90-microF capacitors.

[1]  Robert Plonsey,et al.  Bioelectricity: A Quantitative Approach Duke University’s First MOOC , 2013 .

[2]  R. Yee,et al.  Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. , 1996, Journal of the American College of Cardiology.

[3]  B. Cleland,et al.  A Conceptual Basis for Defibrillation Waveforms , 1996, Pacing and clinical electrophysiology : PACE.

[4]  P. S. Chen,et al.  Effect of capacitor size and pathway resistance on defibrillation threshold for implantable defibrillators. , 1994, Circulation.

[5]  H. A. Blair ON THE INTENSITY-TIME RELATIONS FOR STIMULATION BY ELECTRIC CURRENTS. I , 1932, The Journal of general physiology.

[6]  L A Geddes,et al.  Strength-duration curves for trapezoidal waveforms of various tilts for transchest defibrillation in animals. , 1978, Medical instrumentation.

[7]  L. Geddes,et al.  Bipolar catheter defibrillation in dogs using trapezoidal waveforms of various tilts. , 1980, Journal of electrocardiology.

[8]  P. Kudenchuk,et al.  A Prospective Randomized Comparison in Humans of Biphasic Waveform 60-μF and 120-μF Capacitance Pulses Using A Unipolar Defibrillation System , 1995 .

[9]  M W Kroll,et al.  A Minimal Model of the Single Capacitor Biphasic Defibrillation Waveform , 1994, Pacing and clinical electrophysiology : PACE.

[10]  George A. Johnson,et al.  Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. , 1994, Circulation.

[11]  G. Breithardt,et al.  Biphasic Defibrillation Using a Single Capacitor with Large Capacitance: Reduction of Peak Voltages and ICD Device Size , 1996, Pacing and clinical electrophysiology : PACE.

[12]  P. D. Chapman,et al.  Strength‐Duration Curves of Fixed Pulse Width Variable Tilt Truncated Exponential Waveforms for Nonthoracomy Internal Defibrillation in Dogs , 1988, Pacing and clinical electrophysiology : PACE.

[13]  J. Patrick Reilly,et al.  Electrocutaneous Stimulation with High Voltage Capacitive Discharges , 1983, IEEE Transactions on Biomedical Engineering.

[14]  M. Kroll,et al.  Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface , 2012, Developments in Cardiovascular Medicine.

[15]  M W Kroll,et al.  Smaller Capacitors Improve the Biphasic Waveform , 1994, Journal of cardiovascular electrophysiology.

[16]  P. S. Chen,et al.  Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. , 1996, Journal of the American College of Cardiology.

[17]  B G Cleland A Conceptual Basis for Pacing Waveforms , 1996, Pacing and clinical electrophysiology : PACE.

[18]  R E Ideker,et al.  Ventricular defibrillation using biphasic waveforms: the importance of phasic duration. , 1989, Journal of the American College of Cardiology.

[19]  J. Schuder,et al.  Transthoracic ventricular defibrillation in the dog with truncated and untruncated exponential stimuli. , 1971, IEEE transactions on bio-medical engineering.

[20]  W. Irnich Optimal Truncation of Defibrillation Pulses , 1995, Pacing and clinical electrophysiology : PACE.

[21]  M. Kroll,et al.  A Minimal Model of the Monophasic Defibrillation Pulse , 1993, Pacing and clinical electrophysiology : PACE.

[22]  J E Brewer,et al.  Charge-burping theory correctly predicts optimal ratios of phase duration for biphasic defibrillation waveforms. , 1996, Circulation.

[23]  G. Breithardt,et al.  Optimizing Defibrillation Through Improved Waveforms , 1995, Pacing and clinical electrophysiology : PACE.

[24]  Peng-Sheng Chen,et al.  Short Biphasic Pulses from 90 Microfarad Capacitors Lower Defibrillation Threshold , 1996, Pacing and clinical electrophysiology : PACE.